Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04035317

Aesculus Hippocastanum L. on Fontan Circulation

Effect of Aesculus Hippocastanum L. (Sapindaceae, "Horse Chestnut") on Fontan Circulation - a Randomized Clinical Trial

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Casa Espirita Terra de Ismael · Academic / Other
Sex
All
Age
2 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Patients after the Fontan operation at a single institution will be randomized to receive a standardized extract of Aesculus hippocastanum L. (horse chestnut) or placebo for 4 months in a crossover clinical trial. The primary outcome will be the mesenteric artery resistance measured by Dopple sonography.

Conditions

Interventions

TypeNameDescription
DRUGAesculus Hippocastanum / Horse ChestnutTreatment for 4 months, washout of 4 weeks, then crossover for another 4 months.
DRUGPlaceboTreatment for 4 months, washout of 4 weeks, then crossover for another 4 months.

Timeline

Start date
2017-10-31
Primary completion
2020-12-31
Completion
2020-12-31
First posted
2019-07-29
Last updated
2021-01-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT04035317. Inclusion in this directory is not an endorsement.

Aesculus Hippocastanum L. on Fontan Circulation (NCT04035317) · Clinical Trials Directory